Clinical trial
Influence of Original Native Mitral Valve Lesion (Stenosis or Steno-insufficiency vs. Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Mitral Valve Replacement
NCT07151989 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Original Native Mitral Valve Lesion (Stenosis or Steno-insufficiency vs. Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Mitral Valve Replacement
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2024
- Completion date
- May 1, 2026
- Enrollment
- 3,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
degeneration mitral bioprosthesis